Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dysregulation of Glutamine Utilization in the Pathogenesis of Multiple Myeloma

NCT03119883 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT03119883
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03119883 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dysregulation of Glutamine Utilization in the Pathogenesis of Multiple Myeloma
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Completed
Start date
June 2, 2017
Completion date
June 30, 2024
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

monoclonal gammopathy of undetermined significance, plasma cell myeloma